Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Net Income (2023 - 2025)

Onconetix (ONCO) has disclosed Net Income for 2 consecutive years, with $29.5 million as the latest value for Q4 2024.

  • On a quarterly basis, Net Income rose 234.03% to $29.5 million in Q4 2024 year-over-year; TTM through Dec 2024 was $297286.0, a 100.8% increase, with the full-year FY2024 number at $297286.0, up 100.8% from a year prior.
  • Net Income was $29.5 million for Q4 2024 at Onconetix, up from -$3.8 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $29.5 million in Q4 2024 to a low of -$22.0 million in Q4 2023.